Seer Inc
NASDAQ:SEER

Watchlist Manager
Seer Inc Logo
Seer Inc
NASDAQ:SEER
Watchlist
Price: 2.43 USD 2.1% Market Closed
Market Cap: 143.3m USD
Have any thoughts about
Seer Inc?
Write Note

Seer Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Seer Inc
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Seer Inc
NASDAQ:SEER
Cash Equivalents
$32.5m
CAGR 3-Years
-54%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Cash Equivalents
$4.6B
CAGR 3-Years
-27%
CAGR 5-Years
30%
CAGR 10-Years
24%
Danaher Corp
NYSE:DHR
Cash Equivalents
$2.6B
CAGR 3-Years
1%
CAGR 5-Years
-29%
CAGR 10-Years
-4%
Mettler-Toledo International Inc
NYSE:MTD
Cash Equivalents
$71.6m
CAGR 3-Years
-27%
CAGR 5-Years
-10%
CAGR 10-Years
-6%
Agilent Technologies Inc
NYSE:A
Cash Equivalents
$1.8B
CAGR 3-Years
8%
CAGR 5-Years
0%
CAGR 10-Years
-3%
IQVIA Holdings Inc
NYSE:IQV
Cash Equivalents
$1.6B
CAGR 3-Years
2%
CAGR 5-Years
13%
CAGR 10-Years
9%
No Stocks Found

Seer Inc
Glance View

Market Cap
144.8m USD
Industry
Life Sciences Tools & Services

Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. The company is headquartered in Redwood City, California and currently employs 118 full-time employees. The company went IPO on 2020-12-04. The firm enables scientific outcomes by commercializing products for researchers to unlock biological information. Its initial product, the Proteograph Product Suite (Proteograph), uses its engineered nanoparticle (NP) technology to provide access across the proteome. Its Proteograph Product Suite is comprised of consumables, an automation instrument and software. Its Proteograph provides a workflow, which enables proteomic profiling and the analysis of samples needed to characterize the nature of the proteome. The Company’s Proteograph consumables consist of its NP panel and other consumables necessary to assay samples on its SP100 automation instrument. Its SP100 automation instrument is custom-configured liquid handling workstation. The firm's Proteograph Instrument Control Software (PICS) for the SP100 instrument is fixed and designed to its specified workflow.

SEER Intrinsic Value
2.65 USD
Undervaluation 8%
Intrinsic Value
Price

See Also

What is Seer Inc's Cash Equivalents?
Cash Equivalents
32.5m USD

Based on the financial report for Dec 31, 2023, Seer Inc's Cash Equivalents amounts to 32.5m USD.

What is Seer Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
1%

Over the last year, the Cash Equivalents growth was -39%. The average annual Cash Equivalents growth rates for Seer Inc have been -54% over the past three years , 1% over the past five years .

Back to Top